Coronavirus, Fed meeting, retail sales: What to know in the week ahead
The Federal Reserve is expected to slash interest rates again at its upcoming meeting. …read more […]
The Federal Reserve is expected to slash interest rates again at its upcoming meeting. …read more […]
(Bloomberg) — For more than a year, America’s central bankers have been brainstorming about how to tackle the next downturn — and assuming they had plenty of time to travel around the country figuring it out.It turns out that the Federal Reserve has no time at all.Fed Chair Jerome Powell and his colleagues began 2020 betting they could keep interest rates steady in a strengthening economy. They’re now in a race to save an 11-year expansion from the coronavirus, which has wreaked havoc across financial markets and threatens to tip the U.S. into recession too — if it hasn’t done …read more […]
Is now the right time to invest in stocks? It’s possible that even the most guru-like among Wall Street observers will find the question hard to answer. The markets have yo-yoed dramatically over the last couple of weeks. After posting losses not seen since the 2008 financial meltdown, the S&P 500 closed last week with the best one-day point gain since 2008. As the British investor John Templeton once said, “the time of maximum pessimism is the best time to buy and the time of maximum optimism is the best time to sell.” The coronavirus outbreak has affected the …read more […]
Ford said on Sunday it would shut its Spanish plant in the eastern region of Valencia for one week starting on Monday after three employees tested positive for coronavirus.
Flaring and venting of natural gas are regular practices in the Permian where drillers lack the infrastructure to ship the fuel away …read more […]
Major energy companies in the United States imposed work-from-home rules for office staff and began health checks for remote or critical workers as coronavirus spread across the United States and threatened an industry reeling by falling demand and profits.
Well, that was an exciting week, wasn’t it? We saw the markets make record swings, both in absolute point measure and relative percentages, and both up and down, as investors shifted between panic selling and buying the dip. The week ended on an up note, with the S&P 500 gaining 9% after President Trump’s declaration of a national emergency as well as Federal initiatives to combat the coronavirus and provide economic support. Markets found additional support from the Federal Reserve, which announced a $37 billion bond purchase to inject liquidity into the economy. Oil prices also stabilized on Friday, as …read more […]
When Corning Incorporated (NYSE:GLW) announced its most recent earnings (31 December 2019), I compared it against two… …read more […]
The coronavirus panic is jolting stock markets, with steep drops in major indexes grabbing the public’s attention. But behind the scenes, there is less understood and potentially more worrying evidence that stress is building to dangerous levels in crucial arteries of the financial system.
The coronavirus panic is jolting stock markets, with steep drops in major indexes grabbing the public’s attention. Bankers, companies and individual investors are dashing to stock up on cash and other assets considered safe in a downturn to ride out the chaos. This sudden flight to safety is causing havoc in markets for bonds, currency and loans to a degree that hasn’t been seen since the financial crisis of a dozen years ago. …read more […]
U.S. sportswear giant Nike Inc said on Sunday it is closing all of its stores in the United States and several other countries to limit the spread of the coronavirus.
Readers hoping to buy Philip Morris International Inc. (NYSE:PM) for its dividend will need to make their move… …read more […]
Berlin is trying to stop Washington from persuading a German company seeking a coronavirus vaccine to move its research to the United States, prompting German politicians to insist no country should have a monopoly on any future vaccine.
Chris Anzalone became the CEO of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) in 2007. This report will, first… …read more […]
Berlin is trying to stop Washington from persuading a German company seeking a coronavirus vaccine to move its research to the United States, prompting German politicians to insist no country should have a monopoly on any future vaccine.
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.